메뉴 건너뛰기




Volumn 47, Issue 6, 2001, Pages 855-861

Comparable aciclovir exposure produced by oral valaciclovir and intravenous aciclovir in immunocompromised cancer patients

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; VALACICLOVIR; ANTIVIRUS AGENT; DRUG DERIVATIVE; VALINE;

EID: 0034743782     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (55)

References (26)
  • 21
    • 0029842170 scopus 로고    scopus 로고
    • Valaciclovir: A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections
    • (1996) Drugs , vol.52 , pp. 754-772
    • Perry, C.M.1    Faulds, D.2
  • 22
    • 0034092751 scopus 로고    scopus 로고
    • Valaciclovir: A review of its long term utility in the management of herpes simplex virus and cytomegalovirus infections
    • (2000) Drugs , vol.59 , pp. 839-863
    • Ormrod, D.1    Scott, L.J.2    Perry, C.M.3
  • 24
    • 0028316163 scopus 로고
    • Adverse effects and drug interactions of clinical importance with antiviral drugs
    • (1994) Drug Safety , vol.10 , pp. 281-291
    • Morris, D.J.1
  • 26
    • 0003331763 scopus 로고    scopus 로고
    • Valaciclovir for prevention of recurrent herpes simplex virus infection in HIV-infected individuals - A double-blind controlled trial
    • and the Valaciclovir International HSV Study Group.
    • (1997) Clinical Microbiology and Infection , vol.3 , Issue.SUPPL. 2 , pp. 353
    • Lawrence, A.G.1    Bell, A.R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.